176 related articles for article (PubMed ID: 11728742)
21. Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC.
Karschner EL; Schwope DM; Schwilke EW; Goodwin RS; Kelly DL; Gorelick DA; Huestis MA
Drug Alcohol Depend; 2012 Oct; 125(3):313-9. PubMed ID: 22464363
[TBL] [Abstract][Full Text] [Related]
22. Interpretation of Cannabis Findings in the Hair of Very Young Children: Mission Impossible.
Kintz P; Ameline A; Eibel A; Gheddar L; Feisthauer E; Geraut A; Berthelon L; Farrugia A; Raul JS
Curr Pharm Biotechnol; 2017; 18(10):791-795. PubMed ID: 29189142
[TBL] [Abstract][Full Text] [Related]
23. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
[TBL] [Abstract][Full Text] [Related]
24. Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis.
Desrosiers NA; Himes SK; Scheidweiler KB; Concheiro-Guisan M; Gorelick DA; Huestis MA
Clin Chem; 2014 Apr; 60(4):631-43. PubMed ID: 24563491
[TBL] [Abstract][Full Text] [Related]
25. Analysis of forensic specimens for cannabinoids. II. Relationship between blood delta 9-tetrahydrocannabinol and blood and urine 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid concentrations.
Moody DE; Monti KM; Crouch DJ
J Anal Toxicol; 1992; 16(5):302-6. PubMed ID: 1338218
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid concentrations in spot serum samples 24-48 hours after discontinuation of cannabis smoking.
Skopp G; Pötsch L
J Anal Toxicol; 2008 Mar; 32(2):160-4. PubMed ID: 18334100
[TBL] [Abstract][Full Text] [Related]
27. Detectability of various cannabinoids in plasma samples of cannabis users: Indicators of recent cannabis use?
Kraemer M; Madea B; Hess C
Drug Test Anal; 2019 Oct; 11(10):1498-1506. PubMed ID: 31407526
[TBL] [Abstract][Full Text] [Related]
28. Postmortem redistribution of cannabinoids: Statistical analysis of a novel dataset and meta-analysis.
Tascon I; Côté C; Garneau B; Desharnais B; Gosselin V; Mireault P
Forensic Sci Int; 2023 Dec; 353():111873. PubMed ID: 37944415
[TBL] [Abstract][Full Text] [Related]
29. Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration.
Milman G; Schwope DM; Schwilke EW; Darwin WD; Kelly DL; Goodwin RS; Gorelick DA; Huestis MA
Clin Chem; 2011 Nov; 57(11):1597-606. PubMed ID: 21875944
[TBL] [Abstract][Full Text] [Related]
30. Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.
Karschner EL; Schwilke EW; Lowe RH; Darwin WD; Herning RI; Cadet JL; Huestis MA
J Anal Toxicol; 2009 Oct; 33(8):469-77. PubMed ID: 19874654
[TBL] [Abstract][Full Text] [Related]
31. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ
J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389
[TBL] [Abstract][Full Text] [Related]
32. Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?
Karschner EL; Schwilke EW; Lowe RH; Darwin WD; Pope HG; Herning R; Cadet JL; Huestis MA
Addiction; 2009 Dec; 104(12):2041-8. PubMed ID: 19804462
[TBL] [Abstract][Full Text] [Related]
33. Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol.
Hartman RL; Brown TL; Milavetz G; Spurgin A; Gorelick DA; Gaffney G; Huestis MA
Clin Chem; 2015 Jun; 61(6):850-69. PubMed ID: 26019183
[TBL] [Abstract][Full Text] [Related]
34. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.
Huestis MA; Cone EJ
J Anal Toxicol; 2004 Sep; 28(6):394-9. PubMed ID: 15516285
[TBL] [Abstract][Full Text] [Related]
35. Distribution of ∆(9)-Tetrahydrocannabinol and 11-Nor-9-Carboxy-∆(9)-Tetrahydrocannabinol Acid in Postmortem Biological Fluids and Tissues From Pilots Fatally Injured in Aviation Accidents.
Kemp PM; Cardona PS; Chaturvedi AK; Soper JW
J Forensic Sci; 2015 Jul; 60(4):942-9. PubMed ID: 25800046
[TBL] [Abstract][Full Text] [Related]
36. GC-MS-MS confirmation of unusually high delta 9-tetrahydrocannabinol levels in two postmortem blood samples.
Collins M; Easson J; Hansen G; Hodda A; Lewis K
J Anal Toxicol; 1997; 21(7):538-42. PubMed ID: 9399122
[TBL] [Abstract][Full Text] [Related]
37. Assessing cannabis consumption frequency: Is the combined use of free and glucuronidated THCCOOH blood levels of diagnostic utility?
Hädener M; Martin Fabritius M; König S; Giroud C; Weinmann W
Drug Test Anal; 2017 Jul; 9(7):1043-1051. PubMed ID: 27732768
[TBL] [Abstract][Full Text] [Related]
38. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?
Desrosiers NA; Lee D; Concheiro-Guisan M; Scheidweiler KB; Gorelick DA; Huestis MA
Clin Chem; 2014 Feb; 60(2):361-72. PubMed ID: 24185550
[TBL] [Abstract][Full Text] [Related]
39. Estimating the time of last cannabis use from plasma delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol concentrations.
Huestis MA; Barnes A; Smith ML
Clin Chem; 2005 Dec; 51(12):2289-95. PubMed ID: 16223887
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoid concentrations detected in fatal road traffic collision victims compared with a population of other postmortem cases.
Andrews R; Murphy KG; Nahar L; Paterson S
Clin Chem; 2015 Oct; 61(10):1256-64. PubMed ID: 26240297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
